The increased microparticle surface CD39 described in our study may instead reflect a compensatory mechanism activated by the body in an attempt to mitigate the pro-inflammatory, pro-thrombotic, hyper-proliferative processes associated with IPAH. Here, ENTPD1 is linked to idiopathic pulmonary arterial hypertension.